Transforming T Cell Manufacturing Via Elutriation With The Korus System

The new Korus system uses a gentle elutriation process to give you a cleaner cell population to begin cell therapy production processes such as CAR-T, dendritic cell, tumor-infiltrated lymphocytes (TIL), or IPSC-derived.

Korus’ elutriation protocol would be particularly beneficial for those manufacturing autologous T cell therapies, as it results in the lymphocytes being elutriated and concentrated for the next step in the manufacturing process, such as magnetic bead selection.

Webinar Learning Objectives:

• How incorporating lymphocyte elutriation into your T cell therapy manufacturing process can consistently improve your overall cell yield by up to 2.5X compared to a standard wash process
• The effects of using cleaner lymphocyte populations produced by the Korus on downstream manufacturing operations such as cell selection and expansion
• Early unpublished data on our monocyte elutriation protocol